PLTR
Palantir Technologies Inc.
PLTR's fundamentals are strong and it looks cheap: trading at 120x earnings, about half its usual 252x. Analysts expect strong earnings growth.
SANG
Sangoma Technologies Corporation
There isn't enough reported data to score SANG yet.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
SANG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Under pressure |
SANG's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR's PE is in its cheap range at 120x. If earnings grow as analysts expect, today's price would be 75x next year's earnings.
SANG PE Valuation
SANG has no meaningful PE right now: it lost money over the past year.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
SANG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SANG's losses to shrink, with revenue holding steady.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the stronger earnings trend. Trailing diluted EPS is up 240% for PLTR versus SANG down 400%.
SANG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.15 | +$0.11 |
| Q2 2024 | -$0.26 | +$0.62 |
| Q2 2023 | -$0.88 | +$2.64 |
| Q2 2022 | -$3.52 | -7140% |
| Q2 2021 | $0.05 | -80% |
| Q1 2021 | $0.27 | +17% |
| Q4 2020 | $0.49 | +123% |
| Q3 2020 | $0.29 | 0% |
SANG has swung to a loss: it lost $0.15 per share over the past year, after a profit the year before.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
SANG has the stronger quarterly revenue trend. Revenue is up 96% for PLTR versus up 558% for SANG.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR's operating margin was 47% last quarter, up 14 points from the same quarter a year ago, near the top of its range since 2019.
SANG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $236.7M | -4.3% |
| Q2 2024 | $247.3M | -2.1% |
| Q2 2023 | $252.5M | +13% |
| Q2 2022 | $224.4M | +524% |
| Q2 2021 | $36M | +82% |
| Q1 2021 | $19.7M | +9.2% |
| Q4 2020 | $19M | +9.6% |
| Q3 2020 | $18.4M | +24% |
SANG's revenue has grown year over year for 21 quarters in a row: $237M last quarter, up 558% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -2.7% | +0.9 points |
| Q2 2024 | -3.8% | -12 points |
| Q2 2023 | -13% | -23 points |
| Q2 2022 | -47% | -56 points |
| Q2 2021 | -3.6% | -12 points |
| Q1 2021 | 8.4% | -0.3 points |
| Q4 2020 | 10% | +2.8 points |
| Q3 2020 | 9.7% | +3.9 points |
SANG's operating margin was −2.7% last quarter, up 0.9 points from the same quarter a year ago.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
SANG has the stronger cash trend. Its trailing FCF is up 1,063% versus its history, compared with PLTR at up 370%.
SANG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $39.4M | -1.8% |
| Q2 2024 | $40.1M | +79% |
| Q2 2023 | $22.5M | +17% |
| Q2 2022 | $19.2M | +570% |
| Q2 2021 | $2.9M | -48% |
| Q1 2021 | $1.7M | +83% |
| Q4 2020 | $3.4M | +$5.4M |
| Q3 2020 | $1.7M | +33% |
SANG generated $121M in free cash flow over the past year, more than ten times what it generated the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has the edge over SANG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
SANG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +247K shares |
| 1 year | +76% | +14.5M shares |
| 3 years | +331% | +25.7M shares |
| 5 years | +621% | +28.9M shares |
| Available history | +578% | +28.6M shares |
SANG has 33M diluted shares, up 76% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $2.8M |
| Q2 2023 | $559,000 |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
SANG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 2.9x | Moderate |
| Q1 2021 | 4.1x | High |
| Q4 2020 | -1.6x | Net Cash |
| Q3 2020 | -1.7x | Net Cash |
| Q2 2020 | 2.0x | Healthy |
| Q1 2020 | 2.7x | Moderate |
| Q4 2019 | 3.1x | Elevated |
| Q3 2019 | 0.3x | Very low |
SANG's net debt is about 2.9 years of its operating earnings (EBITDA), up from 2.0 years a year ago.
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
SANG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.1 | Neutral |
| Stochastic | 76.3 | Neutral |
SANG's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
SANG PE vs Technology Sector
| Metric | SANG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
SANG has no meaningful PE right now: it lost money over the past year.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
SANG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.60 | 3.7% above |
| 20 week MA | $4.18 | 14% above |
| 50 week MA | $4.29 | 11% above |
| 100 week MA | $4.98 | 4.2% below |
| 200 week MA | $4.63 | 3% above |
SANG's trend is mixed: it's above four of its five weekly moving averages, and 3% above its 200-week average.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.
SANG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.3 | $18.1 | +36% |
| 2021 | $18.1 | $16.7 | -7.7% |
| 2022 | $16.7 | $3.79 | -77% |
| 2023 | $3.79 | $3.20 | -16% |
| 2024 | $3.20 | $7.00 | +119% |
| 2025 | $7.00 | $5.03 | -28% |
| 2026 YTD | $5.03 | $4.77 | -5.2% |
SANG has the edge over PLTR on returns for 2026, with the stronger performance.